{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:00:47Z","timestamp":1792299647060,"version":"4.4.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Background and Purpose<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            The mechanisms of ischemic stroke in young adults are poorly understood. During the last years, several studies suggested a role for genetic factors predisposing to thrombophilia and for moderate hyperhomocysteinemia in this setting.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Methods<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            We evaluated in 132 consecutive patients (66 males, 66 females; mean\u00b1SD age, 38.4\u00b111.7 years; mean\u00b1SD age at first event, 34.8\u00b110.9 years; range, 6 months to 50 years) referred to our center between January 1997 and December 1999 for a history of young adult ischemic stroke (age at first event, &lt;51 years) the prevalence of factor V (FV) Leiden, prothrombin (FII) G20210A, and C677T and 5,10-methylenetetrahydrofolate reductase (MTHFR) gene mutations and fasting serum total homocysteine levels. Two hundred sixty-two apparently healthy subjects (117 males, 145 females; mean\u00b1SD age, 36\u00b113.2 years) served as controls.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Results<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            Total homocysteine levels differed significantly (\n            <jats:italic>P<\/jats:italic>\n            =0.004,\n            <jats:italic>t<\/jats:italic>\n            test) between patients and controls: 13.03\u00b118.61 versus 10.75\u00b16.24 \u03bcmol\/L (mean\u00b1SD), respectively. In contrast, homozygosity for the\n            <jats:italic>TT<\/jats:italic>\n            mutation of the MTHFR gene was 30 of 132 (22.7%) in patients and 45 of 262 (17.2%) in controls; this difference was not statistically significant (\n            <jats:italic>P<\/jats:italic>\n            &gt;0.05, \u03c7\n            <jats:sup>2<\/jats:sup>\n            test). However, when we stratified the whole population according to genotype, fasting serum homocysteine levels were significantly higher in\n            <jats:italic>TT<\/jats:italic>\n            patients than in\n            <jats:italic>TT<\/jats:italic>\n            controls (25.3\u00b136.8 versus 15\u00b111.6 \u03bcmol\/L;\n            <jats:italic>P<\/jats:italic>\n            =0.02,\n            <jats:italic>t<\/jats:italic>\n            test). Mutations of FV Leiden and of FII G20210A gene are currently reported to be associated with a tendency toward ischemic stroke. Their frequencies were not statistically significantly different between patients and controls in this setting: 7 of 132 (5.3%) versus 17 of 262 (6.5%) for FV Leiden and 10 of 132 (7.6%) versus 16 of 262 (6.1%) for FII G20210A, respectively (all\n            <jats:italic>P<\/jats:italic>\n            &gt;0.05, \u03c7\n            <jats:sup>2<\/jats:sup>\n            test).\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>\n                <jats:bold>\n                  <jats:italic>Conclusions<\/jats:italic>\n                <\/jats:bold>\n                \u2014\n              <\/jats:italic>\n            <\/jats:bold>\n            In the present cohort of patients, moderate hyperhomocysteinemia is the only variable that helps to identify young adults with a history of ischemic stroke.\n          <\/jats:p>","DOI":"10.1161\/hs0102.100483","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T23:16:47Z","timestamp":1027898207000},"page":"51-56","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":81,"title":["Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke"],"prefix":"10.1161","volume":"33","author":[{"given":"Pasquale","family":"Madonna","sequence":"first","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"de Stefano","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coppola","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Cirillo","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Cerbone","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Orefice","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Minno","sequence":"additional","affiliation":[{"name":"From the Dipartimento di Medicina Clinica e Sperimentale, Centro di Coordinamento Regionale per le Emocoagulopatie, Clinica Medica, and Dipartimento di Scienze Neurologiche (G.O.), Universita\u0300 degli studi di Napoli \u201cFederico II,\u201d Naples, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.14.1.6337424"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1986.00520080041017"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"e_1_3_2_5_2","first-page":"2912","volume":"33","year":"1995","unstructured":"Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N Engl J Med. 1995; 33: 2912\u20132917.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3806"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.3.577"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.99.8.999"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3562"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.19.7.1751"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613791"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.21.4.572"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241701"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.10.8091435"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92407-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530130055028"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"e_1_3_2_18_2","first-page":"35","volume":"58","year":"1996","unstructured":"Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996; 58: 35\u201341.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656059"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.24.2406"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.19.3.511"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.16.7.878"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.94.10.2410"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.95.1.21"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.8.2573"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.98.23.2520"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.17.3.569"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.1.7"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.9.1739"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615014"},{"key":"e_1_3_2_31_2","first-page":"208","volume":"99","year":"1999","unstructured":"Harmon DL, Doyle RM, Meleady R, Doyle M, Shields DC, Barry R, Coakley D, Graham IM, Whitehead AS. Genetic analysis of the thermolabile variant of 5,10- methylenetetrahydrofolate reductase as a risk factor for ischemic stroke. Arterioscler Thromb Vasc Biol. 1999; 99: 208\u2013211.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.18.9.1465"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1988.0801001.x"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.3.1215"},{"key":"e_1_3_2_35_2","first-page":"262","volume":"59","year":"1996","unstructured":"de Franchis R, Mancini FP, D\u2019Angelo A, Sebastio G, Fermo I, De Stefano V, Margaglione M, Mazzola G, Di Minno G, Andria G. Elevated total plasma homocysteine and 677C\u2192T mutation of the 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet. 1996; 59: 262\u2013264.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806183382502"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.9.1765"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.12.2507"},{"key":"e_1_3_2_39_2","first-page":"1787","volume":"31","year":"2000","unstructured":"Madonna P, De Stefano V, Coppola A, Albisinni R, Cerbone AM. G20210A PRTH gene mutation and other thrombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke. 2000; 31: 1787\u20131788.","journal-title":"Stroke"},{"key":"e_1_3_2_40_2","first-page":"298","volume":"19","year":"1998","unstructured":"Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y. Polymorphism of the methionine synthase gene: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol. 1998; 19: 298\u2013302.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_3_2_41_2","first-page":"575","volume":"84","year":"2000","unstructured":"De Franchis R, Fermo I, Mazzola G, Sebastio G, Di Minno G, Coppola A, Andria G, D\u2019Angelo A. Contribution of cystathionine \u03b2-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and fasting hyperhomocysteinemia. Thromb Haemost. 2000; 84: 575\u2013582.","journal-title":"Thromb Haemost"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.97.5.437"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.17.6.1157"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119024"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/59.4.940"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.18.3.356"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613864"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/hs0102.100483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T02:10:38Z","timestamp":1715652638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/hs0102.100483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1161\/hs0102.100483"],"URL":"https:\/\/doi.org\/10.1161\/hs0102.100483","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"2001-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-09-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}